Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design (Q46642515)
Jump to navigation
Jump to search
scientific article published in July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design |
scientific article published in July 2011 |
Statements
1 reference
Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design (English)
1 reference
1 reference
T J Povsic
1 reference
M Y Chan
1 reference
S L Zelenkofske
1 reference
W A Wargin
1 reference
R A Harrington
1 reference
J H Alexander
1 reference
C P Rusconi
1 reference
R C Becker
1 reference
1 July 2011
1 reference
32
1 reference
1
1 reference
21-31
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference